Method of diagnosing malaria infection in a patient by surface enhanced resonance raman spectroscopy
Present disclosure relates to a method of diagnosing malaria infection in a patient by Surface Enhanced Raman Spectroscopy (SERS). The method includes obtaining a sample from said patient, mixing the sample with a suspension of magnetic nanoparticles, wherein said magnetic nanoparticles adsorb hemozoin present in the sample onto their surface, obtaining the SERS spectra of the sample, and correlating the obtained SERS spectra to the presence or amount of hemozoin in the sample, wherein the presence of hemozoin is indicative of malaria infection.
1. A method of diagnosing malaria infection in a patient by Surface Enhanced Raman Spectroscopy (SERS), comprising:
obtaining a sample from said patient;
mixing the sample with a suspension of magnetic nanoparticles, wherein said magnetic nanoparticles adsorb hemozoin present in the sample onto their surface;
obtaining the SERS spectra of the sample;
subjecting the sample and suspension of magnetic nanoparticles to a magnetic field prior to and/or during obtaining the SERS spectra of sample, wherein said subjecting comprises applying a magnetic force in a direction of the force of gravity by manipulating a direction of the magnetic field; and
correlating the obtained SERS spectra to the presence or amount of hemozoin in the sample, wherein the presence of hemozoin is indicative of malaria infection, wherein the magnetic nanoparticles comprise a core-shell structure, the shell of the core-shell structure comprises a SERS active metal, and the hemozoin adsorbs onto surfaces of the core-shell structures of the magnetic nanoparticles.
2. The method of claim 1 , wherein obtaining the SERS spectra comprises exciting with a laser source the sample mixed with the suspension of magnetic nanoparticles.
3. The method of claim 2 , wherein subjecting the sample and suspension of magnetic nanoparticles to the magnetic field includes subjecting the sample and suspension of magnetic nanoparticles to the magnetic field prior to and/or during excitation with the laser source.
4. The method of claim 2 , wherein exciting the sample with a laser source comprises exciting the sample with a laser source having a resonant wavelength for hemozoin.
5. The method of claim 4 , wherein exciting the sample with a laser source comprises exciting the sample with a laser source having a wavelength of about 633 nm.
6. The method of claim 1 , wherein the core of the core-shell structure comprises a magnetic material.
7. The method of claim 1 , wherein the core of the core-shell structure comprises Fe 3 O 4 core and the shell of the core-shell structure comprises Ag.
8. The method of claim 1 , wherein the magnetic nanoparticles have magnetic surfaces, respectively, and mixing the sample with the suspension of magnetic nanoparticles includes adsorbing hemozoin present in the sample onto the metallic surfaces at least some of the magnetic nanoparticles.
9. The method of claim 1 , wherein the magnetic nanoparticles each have a magnetic core and a metallic shell directly bonded to the magnetic core, and mixing the sample with the suspension of magnetic nanoparticles includes adsorbing hemozoin present in the sample onto metallic surfaces at least some of the magnetic nanoparticles.